Physician profile
Eric Robert Devore
NPI 1427570464
$17,157.67
in general payments reported to CMS, 2019-2025
19 companies · $919 in 2025
The $919 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $346 · 2021: $313 · 2022: $57.31 · 2023: $238 · 2024: $527 · 2025: $919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,684.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reichert, INC. | $13,250.00 | 2019 | |
| Glaukos Corporation | $743.07 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $616.84 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $448.39 | 2022-2025 | Acuvue |
| Biotissue Holdings INC. | $418.61 | 2019-2024 | |
| Alcon Vision LLC | $364.59 | 2024-2025 | Clareon, Total30, Tryptyr |
| Bausch & Lomb Americas INC. | $199.55 | 2024 | Infuse |
| Dompe US, INC. | $179.93 | 2025 | Oxervate |
| Allergan, INC. | $143.41 | 2019-2021 | |
| Spark Therapeutics, INC. | $125.00 | 2019 | |
| Aerie Pharmaceuticals, INC. | $122.24 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $107.18 | 2019 | |
| Genzyme Corporation | $103.83 | 2025 | |
| Alexion Pharmaceuticals, INC. | $91.32 | 2023 | |
| Lkc Technologies, INC. | $85.86 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $61.07 | 2024 | Misight Contact Lens |
| Sun Pharmaceutical Industries INC. | $40.46 | 2021-2025 | |
| Sight Sciences, INC. | $36.92 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Devore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.